Later, the 2012 anemia practice guidelines of the Kidney Disease: Improving Global Outcomes (KDIGO) group recommended that the upper target of Hb should be 11.5 g/dL and that Hb levels should not exceed 13 g/dL [18]. This evidence concerns the gene GSTM1 and anemia.